HIGGINS JOHN L

Average Profitability
13.79%
Insider Buys Quantity
7
Insider Buys Sum
$181,545.00
Insider Sells Quantity
36
Insider Sells Sum
$36.72M

Insider Activity of HIGGINS JOHN L

According to the SEC Form 4 filings, HIGGINS JOHN L, being in a position of

  1. director at Bio-Techne Corporation,
    оver the last 12 months, has bought 0 shares, and sold 4000 shares for $335,377,
    over all time since 2016-09-08, has bought 0 shares, and sold 53500 shares for $9.83M.

The largest purchase of all time was on 2014-08-15 and amounted to 1000 shares of Ligand Pharmaceuticals Incorporated for $54,970.

The largest sale of all time was on 2018-08-16 and amounted to 21507 shares of Ligand Pharmaceuticals Incorporated for $5.19M.

Biography of HIGGINS JOHN L

No biography is available at this moment.

2024-05-14SaleBio-Techne Corporation
TECH
director
4,000
0.0025%
$83.84$335,377-10.55%
2023-05-23SaleOmniAb, Inc.
OABI
director
9,000
0.0085%
$4.05$36,450+19.95%
2023-05-19SaleOmniAb, Inc.
OABI
director
1,000
0.0011%
$4.05$4,050+34.2%
2023-05-18SaleOmniAb, Inc.
OABI
director
50,000
0.05%
$3.89$194,500+32.02%
2022-12-16SaleLigand Pharmaceuticals Incorporated
LGND
director
10,000
0.0585%
$61.87$618,657+9.29%
2022-11-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
10,000
0.0593%
$78.32$783,173-11.04%
2022-08-10SaleBio-Techne Corporation
TECH
100
0.0003%
$374.89$37,490-14.58%
2022-06-07SaleBio-Techne Corporation
TECH
1,000
0.0025%
$364.31$364,310-10.27%
2020-11-06SaleBio-Techne Corporation
TECH
director
5,000
0.0128%
$300.35$1.5M+37.99%
2020-02-12SaleBio-Techne Corporation
TECH
director
10,000
0.0261%
$205.23$2.05M+27.98%
2019-06-04SaleBio-Techne Corporation
TECH
director
10,000
0.0264%
$203.67$2.04M+2.03%
2018-08-30SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
3,500
0.0166%
$258.25$903,875-52.06%
2018-08-23SaleBio-Techne Corporation
TECH
director
20,000
0.0442%
$156.48$3.13M+3.5%
2018-08-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
12,993
0.0602%
$243.00$3.16M-49.81%
2018-08-16SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
21,507
0.1024%
$241.33$5.19M-48%
2018-05-15SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
12,405
0.0051%
$16.14$200,217-13.7%
2018-02-15SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
9,000
0.0424%
$157.03$1.41M+8.91%
2018-01-24SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
22,500
0.1069%
$165.00$3.71M+4.52%
2018-01-19SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
28,099
0.0624%
$73.40$2.06M+9.87%
2017-11-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
2,258
0.0107%
$140.34$316,888+22.01%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.